 |
 |
China sales, Singulair drive Merck’s Q1-2012 net to $3 bn
28 April 2012
|
|
|
|
Merck, Brazil’s Supera Farma to form JV for generic drugs
16 February 2012
|
|
|
Merck to pay $950 million to settle Vioxx drug charges
24 November 2011
|
| | |
|
|
Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million
29 September 2011
|
|
|
Merck & Co to axe 13,000 more jobs by 2015
30 July 2011
|
|
|
Sun to co market Merck's Diabetes drugs in India
25 April 2011
|
|
|
Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US
23 April 2011
|
|
|
Merck, Sun Pharma in generics JV
11 April 2011
|
|
|
Merck hopes to be among top-five drugmakers in India
11 March 2011
|
|
|
Merck and Ranbaxy end drug development pact
06 January 2011
|
|
|
Merck to buy diabetes drug developer SmartCells in a $500 million-plus deal
03 December 2010
|
|
|
Merck aims for top slots in seven emerging markets
15 November 2010
|
|
|
Merck enters drug distribution pact with South Africa's Adcock Ingram
24 June 2010
|
|
|
Merck settles Zetia patent suit with Glenmark
11 May 2010
|
|
|
Battelle, IBM, Merck join UPMC’s effort to produce vaccines
12 March 2010
|
|
|
Merck receives EC approval for infertility treatment drug Elnova
28 January 2010
|
|
|
Former CDC chief Dr. Julie Gerberding appointed president of Merck Vaccines
22 December 2009
|
|
|
Merck wins summary judgment in Vioxx lawsuit in Texas
23 November 2009
|
|
|
Merck receives FDA approval for new fertility drug for women
21 November 2009
|
|
|
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
30 October 2009
|
|
|
Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies
29 September 2009
|
|
|
Merck, Wellcome Trust tie up to make affordable drugs in India
19 September 2009
|
|
|
Judge declares mistrial in Merck's Fosamax case
12 September 2009
|
|
|
Merck wins court ruling on Singulair patent
20 August 2009
|
|
|
Merck, Schering-Plough shareholders approve $41-billion deal
10 August 2009
|
|
|
Merck’s Q2 profit falls, but beats expectations
22 July 2009
|
|
|
Merck, Schering-Plough settle Vyotorin dispute with states
16 July 2009
|
|
|
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
|
|
|
Merck plans buy-back of 35 per cent equity at Rs435 a share
20 May 2009
|
|
|
Pharma majors under merger pressure after Merck-Schering deal
12 March 2009
|
|
|
Merck to acquire Schering- Plough for $41 billion
09 March 2009
|
|
|
Merck launches division for follow-on biotech drugs
11 December 2008
|
|
|
FDA bars use of Merck's cancer vaccine by women over 27
26 June 2008
|
|
|
Ranbaxy to develop new drugs for Merck & Co
10 May 2008
|
|
|
Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants
03 May 2008
|
|
|
US FDA turns down Merck's ER niacin / laropiprant
29 April 2008
|
|
|
Shasun Chemicals technology licenses API technology to Merck
27 February 2008
|
|
|
Nicholas Piramal in R&D collaboration with Merck & Co
19 November 2007
|
|
|
Merck agrees to settle Vioxx claims for $4.85 billion
15 November 2007
|
|
|
Merck buys cardiac biotech
start-up NovaCardia
31 July 2007
|
|
|
Merck to acquire NovaCardia
for $350 million
27 July 2007
|
|
|
Court
revives shareholder lawsuits over Vioxx against Merck
20 July 2007
|
|
|
Ranbaxy withdraws bid for Merck's generic business
20 March 2007
|
|
|
Ranbaxy enters second round of bidding for Merck unit: report
16 March 2007
|
|
|
Merck suffers adverse Vioxx lawsuit in the US
13 March 2007
|
|
|
Dr Reddy's to join the race for Merck's generic business
05 February 2007
|
|
|
Ranbaxy to bid over $5 billion for Merck Generics
09 January 2007
|
|
|
Tata
Group''s Advinus to develop metabolic drugs for Merck
16 November 2006
|
|
|
Merck & Co develops new diabetes drug
14 June 2006
|
|
|
Merck wins second Vioxx lawsuit
18 February 2006
|
|
|
Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs
02 February 2006
|
|
|
Dr Reddy's Laboratories enters into agreement with Merck
01 February 2006
|
|
|
Merck, ICMR to conduct joint trials on cervical cancer vaccine
22 December 2005
|
|
|
Merck antifungal drug faces key U.S. panel test
16 February 2001
|
